期刊文献+

肾性高血压和IgA肾病病人红细胞钠/锂逆转运率的变化 被引量:2

Red-cell sodium-lithium countertransport in patientswith IgA nephrology and renal hypertention
原文传递
导出
摘要 应用改良的Canessa氏法,测定了21例ⅠgA肾病病人(ⅠgAN)、13例肾实质性高血压病人(RHT)的红细胞钠/钾逆转运率(RBCNa+/Li+CT)活性,并与23例正常人(NOR)及ll例原发性高血压病人(EHT)进行对照。结果:(1)EHT及其有高血压家族史的EHT病人RBCNa+/Li+CT均明显高于正常人;(2)伴高脂血症的RHT病人RBCNa+/Li+CT明显升高;(3)单纯高脂血症及高脂血症伴高血压的ⅠgAN病人RBCNa+/Li+CT明显高于正常人;(4)34例肾脏病病人RBCNa+/Li+CT与血清胆肥固醇水平呈正相关。结果提示RBCNa+/Li+CT活性增高是原发性高血压的“遗传标志”;部分肾性高血压病人及ⅠgAN病人的RBCNa+/Li+CT活性增高可能与伴发高脂血症有关。 o find changes in activity of red-cellsodium-lithium counter transport (RBC Na+/Li+CT) in IgA nephrology (IgAN) and renalhypertension (RHT), we measured the activity of RBCNa+ / Li+CT in 21 patients with IgAN and 13 patientswith RHT and compared it with that in 23 noimalpersons and 17 essential hypertension (EHT) patientsby improved Canessa's method. RBC Na+ / Li+CT ac-tivity in the EHT patients and EHT patients with posi-tive family history was significantly higher than that innornial group. The activity of RBC Na+/ Li+CT inthe hyperlipidemic RHT patients was increased ascompared with the normal group. The activity of RBCNa+/ Li+CT in IgAN patients with hyperlipidemiaand hyperlipidemic hypertensive IgAN patients wassignificantly higher than that in normal group. Therewas positive correlation between the activity of RBCNa+ / Li+CT and serum cholesterol level in 34 patientswith renal disease. The results indicate that enhancedactivity of Na+ / Li+ CT is a genetic marker for EHTpatients, and hyperlipidemia is probably related to theenhanced activity of RBC Na+/ Li+ CT in parts ofRHT patients and IgAN patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 1994年第4期214-217,共4页 National Medical Journal of China
关键词 肾疾病 血脂过多 肾性高血压 Hypertension, renal Kidneydiseases Hyperlipidemia.
  • 相关文献

参考文献1

  • 1赵光胜,临床高血压病学,1990年

同被引文献7

  • 1Hasslacher C.Ritz E.Wahl P.et al.Slmilar risk of nephropathy in patinets with type I or type I diabetes mellitus.Nephrol Dial Transplant,1989.4:859.
  • 2Canessa M,Adragna N,Solomon HS,et al.Increased sodium-lithium countertransport in RBC of patients with esscntial hyperrension.N Eng J Med,1980,302:772.
  • 3Carr SJ,Mbanaya JC,Thomas T,et al.Increase in glomerular filtration rate in patienta with IDDM and elevated erythrocyte sodium-lithium countertransprot.N Engl J Med,1990,322:50.
  • 4Manjili R,Bending JJ,Scott G,et al:Increased sodiumlithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy.N Engl J Med,1988,318:146.
  • 5Barzilay GC,Warram JH,Bak M,et al.Predisposition to hypertension:Risk factor for nephropathy and hyperlension in IDDM,Kidney Int,1992,41:723.
  • 6Rutherford PA,Thomas TH,Wilkinson R,et al.Etythrocyte sodium-lithium countertransport clinical.useful.pathopysiologcally instructive or just phenomenology? Clin Sci,1992,82:341.
  • 7Fujita J,Obayashi Y,Tsuda K,et al.Erythrocyte sodiumlithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropath in NIDDM,Diabetes Care,1994,17:977.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部